CREBBP and Alzheimer disease: Metformin could ameliorate AD symptoms by inhibiting neuronal loss, activating atypical PKC-CREB-binding protein (aPKC-CBP) signaling pathway in neural precursors, or decreasing the accumulation of Aβ (Liao et al., 2022).